Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lillicrap

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Thrombosis Research|May 11, 2007
Von Willebrand disease - phenotype versus genotype: deficiency versus diseaseDavid Lillicrap
Hematology. American Society of Hematology. Education Program|November 25, 2006
The role of immunomodulation in the management of factor VIII inhibitorsDavid Lillicrap
Vox Sanguinis|March 6, 2003
Gene expression: overview and clinical implicationsDavid Lillicrap
Blood|June 27, 2013
Introduction to a series of reviews on cancer-associated thrombotic diseaseDavid Lillicrap
Hematology. American Society of Hematology. Education Program|December 10, 2013
von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapyDavid Lillicrap
Circulation|August 16, 2017
Thrombolytic Potential of <i>N</i>-Acetylcysteine: Evidence for Significant Benefit in Mitigating Arterial ThrombosisDavid Lillicrap
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
The World Federation of Hemophilia and researchDavid Lillicrap
Blood|April 7, 2022
Low von Willebrand factor phenotype: the enigma continuesDavid Lillicrap
Blood|May 7, 2026
Generational advancement of factor VIIIa mimeticsDavid Lillicrap
Pediatric Blood & Cancer|October 31, 2012
The future of hemostasis managementDavid Lillicrap
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Thrombosis Research|May 11, 2007
Von Willebrand disease - phenotype versus genotype: deficiency versus diseaseDavid Lillicrap
Hematology. American Society of Hematology. Education Program|November 25, 2006
The role of immunomodulation in the management of factor VIII inhibitorsDavid Lillicrap
Vox Sanguinis|March 6, 2003
Gene expression: overview and clinical implicationsDavid Lillicrap
Blood|June 27, 2013
Introduction to a series of reviews on cancer-associated thrombotic diseaseDavid Lillicrap
Hematology. American Society of Hematology. Education Program|December 10, 2013
von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapyDavid Lillicrap
Circulation|August 16, 2017
Thrombolytic Potential of <i>N</i>-Acetylcysteine: Evidence for Significant Benefit in Mitigating Arterial ThrombosisDavid Lillicrap
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
The World Federation of Hemophilia and researchDavid Lillicrap
Blood|April 7, 2022
Low von Willebrand factor phenotype: the enigma continuesDavid Lillicrap
Blood|May 7, 2026
Generational advancement of factor VIIIa mimeticsDavid Lillicrap
Pediatric Blood & Cancer|October 31, 2012
The future of hemostasis managementDavid Lillicrap
Pageof 22